YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
FungiXpert Cryptococcal Antigen Rapid Test Successfully Approved by Health Canada
We are pleased to announce that our Cryptococcal Capsular Polysaccharide Detection K-Set (Lateral Flow Assay) has b...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Era Biology at ECCMID 2023, Denmark
Era Biology, a leader and pioneer of invasive fungal disease (IFD) diagnostics field, has exhibited at the European Congress of Clinical Microbiology and Infecti...
Day 2 at ISHAM 2022
New Delhi, India – September 21, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Society for Human and Animal Mycology (IS...